Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Discussion In approximately 50% of all combinations, co-administration of DOACs and SMIs results in moderately potent or potent DDIs. Thus, many relevant DDIs may occur, and this requires interference by the physician to prevent ineffective treatment or increased risk of bleeding caused by DOACs. Edoxaban never causes relevant DDIs that require intervention of physicians, as DDIs are categorised as yellow at most.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
